Spiber® is a biomaterial made of recombinant spider silk protein with a unique set of properties. Spiber® can be processed into a variety of two- and three-dimensional formats equipped with functional properties that are ideal for cell culturing and many other biomedical applications.

Established in September 2007, Spiber Inc. is a Japanese biotechnology startup utilizing cutting-edge synthetic biology, polymer, and material science for the development of its novel Brewed Protein™ materials. Produced through microbial fermentation and utilizing agricultural feedstocks as primary raw materials, Brewed Protein™ polymers are well-positioned to make significant contributions to animal- and plastic-free initiatives in a range of fields such as the apparel and automotive industries. Leveraging its R&D expertise, Spiber pursues its mission of positively contributing to sustainable human well-being. Operation of Spiber’s first mass production plant in Rayong Province, Thailand, is slated to commence within 2021. The company is also constructing a second mass production facility with partner ADM in Iowa, USA, which is scheduled to begin operating in 2023 at the earliest.

AMSilk GmbH engages in the production of fiber and biopolymers.It offers implant coating, medical devices for OTC wound care, functional cosmetics, cell biology device kits, biosteel spidersilk fibers and spidersilk research license. It serves the biosteel fibers, medical devices, and cosmetic ingredients industry. The firm's materials are to be applied in numerous fields to improve existing products or to develop materials for completely new applications, which could not be realized until now due to the lack of an appropriate material. The company was founded by Axel H. Leimer, Thomas Scheibel, and Lin Römer in 2008 and is headquartered in Planegg, Germany.

Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future. Biofabricated silk fibers MicrosilkTM - based on proteins found in nature, produced using Bolt Threads proprietary technology and revolutionary bioengineering concepts. Next-generation of performance fibers, fabrics and luxury products that represent cutting-edge technology in science, while raising the bar for quality, performance, and design.

Seevix Material Sciences Ltd. is an Israeli company located in Jerusalem. The firm manufactures biopolymer products. It was founded in 2014 by Shlomzion Shen, who has been the CEO since then.\nThe company says this about itself: Seevix was established in 2014. Its patented SVX synthetic spidersilk, backed by over ten years of research at the Hebrew University, is manufactured by means of a single-step production process, enabling scalable, green, commercial manufacturing that reduces production time and costs. Seevix's exceptional multidisciplinary R&D team of biologists, chemists and material engineers is dedicated to creating next-generation SVX-based products in a host of different industries, providing its partners with a sustainable competitive edge.

Engages in the research and development of biological technologies

Sinopec Beijing Research Institute of Chemical Industry engages in the research in petrochemical industry. Its core products include Select hydrogenation and cryogenic methanation catalyst and process, Polyolefin catalyst, Napro® Additives, and Ethylene oxide silver catalyst. It also involves in technical services, technical consulting, technical training, and technical support. The company was founded in June 1958 and is headquartered in Beijing, China.

Kojima Industries Corp. designs, manufactures and distributes metal, resin and electronic parts. The firm also produces interior and exterior parts for cars. The company was founded on May 20, 1938 and is headquartered in Toyota, Japan.

The Brazilian Agricultural Research Corporation (Embrapa) was founded on April 26, 1973, and is under the aegis of the Brazilian Ministry of Agriculture, Livestock, and Food Supply. Since our foundation, and with our partners from the National Agricultural Research System, we have taken on the challenge to develop a genuinely Brazilian model of tropical agriculture and livestock to overcome the barriers that limited the production of food, fiber, and fuel in our country. This effort has helped to change Brazil. Nowadays, our agriculture is one of the most efficient and sustainable ones in the planet. We have incorporated a wide area of formerly degraded Cerrado lands into our production systems; a region that now accounts for nearly 50% of our grain production. We have quadrupled the beef and pork supply and increased the chicken supply 22-fold. These are some of the achievements that took the country from the condition of basic food importer to one of the world's largest food producers and exporters.

Kraig Biocraft Laboratories, Inc. operates as a biotechnology company, which focuses on the development and commercialization of spider silk. It specializes in the global textiles industry, genetic research and product development. The company was founded by Kim K. Thompson on April 25, 2006 and is headquartered in Ann Arbor, MI.

Gustav Pirazzi & Comp. GmbH & Co. KG is a private company headquartered in Offenbach am Main, Germany. The firm manufactures musical instruments. Eva M��ller-Zierach is currently the CEO of the company.

Adidas strives to be the leading sports brand in the world an ambitious yet realistic goal. One major lever to achieve this is the brand broad and unique product portfolio spanning from apparel and footwear for professional athletes to premium fashion. It allows adidas to address multiple consumer needs, tackle market opportunities from various angles as well as be less affected by one-dimensional market risks. This product portfolio as well as adidas commitment to excel in all relevant segments differentiates the brand from competitors and ensures solid market growth, while staying true to the brand values. Currently, the brand focuses on five global priorities: Football, Running, Training, Basketball and Originals.

Suzhou Baiyuan Gene Technology Co., Ltd., established on 2012-07-12, Business scope includes genomics,Basic Medicine,Preventive Medicine and Hygiene,pharmaceutical research;medical instruments,Chinese patent medicine,biopharmaceuticals,Healthy food,development of cosmetics;Non-hazardous teaching and research reagents,Teaching and scientific research equipment,Electronic and automation instrument,Wholesale of medical devices,retail;Production of Medical Devices;Technical consultation related to the above products,technology transfer,Technical service and technical outsourcing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Import and export;Technology Import and Export;Import and export agency;Drug import and export;Import and export of goods managed by state trade;Import and export commodity inspection and appraisal(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Hardware retail;Sales of special labor protection products;Chemical product sales(No licensed chemical products);Arts and crafts and etiquette supplies sales(Except for ivory and its products);Communication equipment sales;Sales of electronic components and electromechanical components;Sales of mechanical and electrical equipment;Textile,Wholesale of Clothing and Household Goods;Specialty Chemicals Sales(Free of Hazardous Chemicals);General merchandise sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Boston Scientific Ltd., part of Boston Scientific Corp., is a British company located in Hemel Hempstead. The firm distributes medical products. It was founded in 1992.\nThe company says this about itself: Boston Scientific Ltd designed, manufactured and sold transvaginal mesh (“TVM”) medical devices that were implanted into thousands of Canadian women for the treatment of Stress Urinary Incontinence (“SUI”) and Pelvic Organ Prolapse (“POP”).

Immunovia is a strategic center for translational cancer research in Lund, Sweden. Immunovia’s strategy is to decipher a large amount of information in the blood and translate it into clinically useful tools to diagnose complex diseases such as cancer and to do this earlier and more accurately than previously possible. Immunovia’s core technology platform, IMMray™, is based on antibody microarray analysis.

EntoGenetics is a biomaterials company producing spider silk from genetically engineered silkworms. Its services mainly focus on commercializing spider silk from engineered silkworms which can be used in biomedical and textile applications that enable users to get access to inexpensive spider silk in an easy manner.

Hainan Spider King Biotechnology Co., Ltd., established on 2010-09-14, Business scope includes technical research in the field of biomaterials,Development of biological products,production and sales,Chinese patent medicine,biopharmaceuticals,Medicinal wine,Healthy food,drinks,cosmetic,Development of daily chemical products,production and sales,Processing and sales of Chinese herbal medicines,medical instruments(one type,medical dressing)production and sales of,Sanitation products(except dangerous products)production and sales of,Processing and sales of living spiders and handicrafts,Production, processing and sales of pre-packaged food and bulk food.(General operating items self-management,Licensed business projects are operated on the basis of relevant licenses or approval documents)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.

Jiangsu Jingsen Biomedical New Material Technology Co., Ltd., established on 2010-06-13, Business scope includes biomedical new materials and products,medical supplies,hygiene products,cosmetic,food research and development,technology transfer,Technical Consulting and Technical Services;Biological reagents for scientific research(medicine,Hazardous chemicals excluded)R & D and sales;food business(Subject to the items listed in the food business license);biochemical products(medicine,Hazardous chemicals excluded),medical instruments(limit<Medical Device Business License>Approved scope),hygiene products,sales of cosmetics;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:food production;Cosmetic production;Production of Class II Medical Devices;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Manufacturing of bio-based materials;Sales of bio-based materials;Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zhejiang Chaosi Biotechnology Co., Ltd., established on 2016-10-18, Business scope includes technology development,technical consulting:Biotechnology,medical technology,Product Quality Inspection Technology;technology development,Technical Services,technical consulting,Achievement transfer:new energy technology,new material technology